Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02896699 · ClinicalTrials.gov registry record · NA
Advanced HIV Prevention (PrEP Chicago)
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 424
- Enrollment target
NCT02896699: Completed NA study, sponsored by University of Chicago.
NCT02896699 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 424 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02896699, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 424 participants
- Enrollment target
Study Summary
This study will evaluate the feasibility of a network intervention to train individuals to disseminate PrEP information and motivate initial PrEP interest and knowledge of PrEP in their social networks.
Interventions
- OTHER Control Group
- BEHAVIORAL PrEP Intervention Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 424 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-08 |
| Phase | NA |
What the finished NCT02896699 record still lists
NCT02896699 is an interventional study that assigns participants to a tested intervention. The registered 424 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.
NCT02896699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02896699 about?
NCT02896699 is a clinical study titled "Advanced HIV Prevention (PrEP Chicago)". This study will evaluate the feasibility of a network intervention to train individuals to disseminate PrEP information and motivate initial PrEP interest and knowledge of PrEP in their social networks.
What is the current status of trial NCT02896699?
This trial is currently completed. It is a NA study. The enrollment target is 424 participants. The study started on 2016-03. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02896699?
The interventions under investigation include: Control Group (OTHER), PrEP Intervention Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02896699?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02896699's enrollment target sits among peer trials
424 238th of 2000 higher than 1,763 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05632770 · 424 participants · NA
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
- NCT05733767 · 424 participants · Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- NCT06978127 · 424 participants · NA
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
- NCT07140913 · 424 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia